PAR-T FOR SOLID TUMORS

Globally, translation of immunotherapy to solid tumors has been challenging. At Tychon, we have been focused on solid tumor treatments from the very beginning achieving impressive preclinical results against breast, lung, prostate and ovarian cancers.

PAR-T Cells in Action

Traveling (moving) cells are PAR-T cells. Stationary cell are cancer cells

PAR-T cells circulate until they come in contact with specific antigens presented on the surface of cancer cells. Once the cancer antigen is recognized, the PAR-T cells attach and lyse (kill) and eliminate the cancer cells.